Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Dutka

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 8, 2019
Authors' ReplyLiam Ring, Yasir Abu-Omar, Nikki Kaye, et al.
JACC. Heart Failure|June 23, 2014
Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy)Anna C Kydd, Fakhar Z Khan, William D Watson, et al.
Journal of Interventional Cardiology|November 3, 2010
Elective coronary stenting increases fractional flow reserve in other arteries due to an increase in microvascular resistance: clinical implications for assessment of multivessel diseaseStephen P Hoole, Patrick M Heck, Andrew C Epstein, et al.
Circulation|January 30, 2002
Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteriesKim Rajappan, Ornella E Rimoldi, David P Dutka, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 11, 2012
Coronary collaterals provide a constant scaffold effect on the left ventricle and limit ischemic left ventricular dysfunction in humansStephen P Hoole, Paul A White, Philip A Read, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 24, 2011
Impact of VV optimization in relation to left ventricular lead position: an acute haemodynamic studyFakhar Z Khan, Munmohan S Virdee, Philip A Read, et al.
Angiology|December 25, 2008
Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary interventionStephen P Hoole, Patrick M Heck, Paul A White, et al.
Circulation. Cardiovascular Interventions|May 19, 2011
A pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humansPhilip A Read, Stephen P Hoole, Paul A White, et al.
Cardiovascular Diabetology|August 9, 2015
Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitusLiam M McCormick, Patrick M Heck, Liam S Ring, et al.
Circulation. Cardiovascular Interventions|May 23, 2013
Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-upWilliam R Davies, Adam J Brown, William Watson, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 8, 2019
Authors' ReplyLiam Ring, Yasir Abu-Omar, Nikki Kaye, et al.
JACC. Heart Failure|June 23, 2014
Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy)Anna C Kydd, Fakhar Z Khan, William D Watson, et al.
Journal of Interventional Cardiology|November 3, 2010
Elective coronary stenting increases fractional flow reserve in other arteries due to an increase in microvascular resistance: clinical implications for assessment of multivessel diseaseStephen P Hoole, Patrick M Heck, Andrew C Epstein, et al.
Circulation|January 30, 2002
Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteriesKim Rajappan, Ornella E Rimoldi, David P Dutka, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 11, 2012
Coronary collaterals provide a constant scaffold effect on the left ventricle and limit ischemic left ventricular dysfunction in humansStephen P Hoole, Paul A White, Philip A Read, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 24, 2011
Impact of VV optimization in relation to left ventricular lead position: an acute haemodynamic studyFakhar Z Khan, Munmohan S Virdee, Philip A Read, et al.
Angiology|December 25, 2008
Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary interventionStephen P Hoole, Patrick M Heck, Paul A White, et al.
Circulation. Cardiovascular Interventions|May 19, 2011
A pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humansPhilip A Read, Stephen P Hoole, Paul A White, et al.
Cardiovascular Diabetology|August 9, 2015
Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitusLiam M McCormick, Patrick M Heck, Liam S Ring, et al.
Circulation. Cardiovascular Interventions|May 23, 2013
Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-upWilliam R Davies, Adam J Brown, William Watson, et al.
Pageof 6